Abstract |
The main aim of this study was to compare the response to trivalent inactivated influenza vaccine in children who received a kidney transplant and were on steroid-free versus steroid-based immunosuppression. Groups: 1. Kidney transplant recipients on steroid-free immunosuppression (n=27); 2. Kidney transplant recipients on steroid-based immunosuppression (n=39); 3. Healthy controls (n=21). Hemagglutination inhibition titers against 2007-2008 A/H1N1 and A/H3N2 and B strains were measured before and 8 weeks postvaccination. Postvaccination geometric mean titers to A/H1N1 were significantly lower among both transplant groups than controls (p=0.025 and 0.015, respectively). Postvaccination titers to H3N2 and B strains were not statistically different between groups. Proportions of participants developing seroprotection were not different among groups. Both kidney transplant groups seroconverted less than controls for A/H1N1 (p=0.0002) and were no different from controls for B. For A/H3N2, the steroid-free group had the weakest seroconversion (p=0.008), possibly due to mycophenolate-enhanced exposure and a younger age. Overall, children after kidney transplantation demonstrated a good serologic response to the inactivated influenza vaccine although somewhat lower than controls. Steroid-free immunosuppression did not seem to present an advantage in antibody response. Data on inactivated influenza vaccine safety and efficacy was collected and demonstrated absence of acute rejection or laboratory-proven influenza for 6 months postvaccination.
|
Authors | Corina Nailescu, Xiyan Xu, Hong Zhou, Henrietta Hall, Amy C Wilson, Jeffrey D Leiser, Deepa H Chand, Rudolph P Valentini, Diane Hebert, John D Mahan |
Journal | Pediatric nephrology (Berlin, Germany)
(Pediatr Nephrol)
Vol. 26
Issue 3
Pg. 459-67
(Mar 2011)
ISSN: 1432-198X [Electronic] Germany |
PMID | 21181206
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Viral
- Immunosuppressive Agents
- Influenza Vaccines
- Steroids
|
Topics |
- Acute Disease
- Adolescent
- Antibodies, Viral
(blood)
- Canada
- Chi-Square Distribution
- Child
- Female
- Graft Rejection
(immunology, prevention & control)
- Hemagglutination Inhibition Tests
- Humans
- Immunization Schedule
- Immunosuppressive Agents
(adverse effects, therapeutic use)
- Influenza A Virus, H1N1 Subtype
(immunology)
- Influenza A Virus, H3N2 Subtype
(immunology)
- Influenza Vaccines
(administration & dosage, adverse effects)
- Influenza, Human
(prevention & control, virology)
- Kidney Transplantation
(adverse effects)
- Male
- Steroids
(adverse effects, therapeutic use)
- Time Factors
- Treatment Outcome
- United States
|